In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
The burden of inflation has increased on the common man from today (July 18). Last month, the GST
NIOS Examination Centres: The Supreme Court has directed the National Institute of Open Schooling
China is rapidly building a bridge over Pangong Lake, satellite image revealed
The standoff between India and China in eastern Ladakh does not seem to be diminishing. Tensions
Former Sri Lankan President Gotabaya Rajapaksa has applied for a green card to settle in the US.
There has been a big change in the list of top billionaires of the world. While Tesla CEO Elon Mu
The BJP has called a meeting of its leaders on the issue of the inclusion of non-local voters in
Corona Updates: 1,716 new cases found in 24 hours, 3 patients died; 400 active patients reduced
In the last 24 hours, 1,716 new cases of corona have been reported in the country and 3 patients
This Likhpune road accident is in the news these days. Here a speeding luxury car hit a
The World Health Organization (WHO) issued an alert on Wednesday regarding 4 cough syrups made by
Netflix and YRF Entertainment's series 'The Railway Men' is going to be released shortly from now
